Brief: Emmaus Life Sciences Posts Q1 Loss Per Share $0.03
13/05/2022 13:38
May 13 (Reuters) - Emmaus Life Sciences Inc EMMA.PK :
* EMMAUS LIFE SCIENCES REPORTS Q1 2022 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
* Q1 LOSS PER SHARE $0.03
* Q1 REVENUE $3.2 MILLION
Source text for Eikon: ID:nPn3Yqprsa
Further company coverage: EMMA.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns